Insider · CIK 0001340875
Chen Schor
ceopresidentofficerdirector
Files at KPTI (Karyopharm Therapeutics Inc.), ACET (Adicet Bio, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 28, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +4,600 | $0.00 | $0 | 4,600 | May 29, 2025 |
| Jan 31, 2025 | ACET Adicet Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +763,829 | $0.00 | $0 | 763,829 | Feb 4, 2025 |
| Jan 24, 2025 | ACET Adicet Bio, Inc. | FTax withholding Common Stock | -28,101 | $0.92 | $26k | 137,201 | Jan 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.